HALL LAURIE J TRUSTEE - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2022$07400.0%0.00%
Q2 2022$07400.0%0.00%
Q1 2022$07400.0%0.00%
Q4 2021$0
-100.0%
7400.0%0.00%
Q3 2021$1,000
-50.0%
740
-37.3%
0.00%
-100.0%
Q2 2021$2,0000.0%1,1800.0%0.00%0.0%
Q1 2021$2,000
+100.0%
1,1800.0%0.00%
Q4 2020$1,000
-50.0%
1,1800.0%0.00%
-100.0%
Q3 2020$2,0001,1800.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders